In Competition Law and Policy Debate, Raphaël De Coninck highlights the European Commission’s recent interest in assessing the impact of pharmaceutical mergers on innovation. The article discusses the Commission’s approach and argues in favor of developing a consistent framework for assessing the impact of mergers on innovations. To read more, click the link below.
The Media Show - Reporting on the Abuse of Power
Philip Marsden discusses some of the ramifications of the UK Government’s approach to Digital Regulation, ahead of the Queen’s Speech this week. For more...